000 01123 a2200325 4500
005 20250517061220.0
264 0 _c20161007
008 201610s 0 0 eng d
022 _a1751-2441
024 7 _a10.1586/17512433.2015.1102051
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTrainor-Moss, Santiago
245 0 0 _aSchistosomiasis therapeutics: whats in the pipeline?
_h[electronic resource]
260 _bExpert review of clinical pharmacology
_c2016
300 _a157-60 p.
_bdigital
500 _aPublication Type: Editorial
650 0 4 _aAnimals
650 0 4 _aDrug Design
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aNeglected Diseases
_xdrug therapy
650 0 4 _aPraziquantel
_xtherapeutic use
650 0 4 _aSchistosoma
_xdrug effects
650 0 4 _aSchistosomiasis
_xdrug therapy
650 0 4 _aSchistosomicides
_xtherapeutic use
650 0 4 _aTropical Climate
700 1 _aMutapi, Francisca
773 0 _tExpert review of clinical pharmacology
_gvol. 9
_gno. 2
_gp. 157-60
856 4 0 _uhttps://doi.org/10.1586/17512433.2015.1102051
_zAvailable from publisher's website
999 _c25394009
_d25394009